Yiheng Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Yiheng Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,143,497	Closed	-$52.2M	–	35
2023 Q1	$52.2M	Sell	2,143,497 -1,469,757	-41%	-$32.2M	2.06%	10
2022 Q4	$77.4M	Hold	3,613,254	–	–	3.42%	9
2022 Q3	$64.8M	Sell	3,613,254 -1,445,331	-29%	-$19M	4%	10
2022 Q2	$48.7M	Hold	5,058,585	–	–	2.78%	11
2022 Q1	$85.1M	Hold	5,058,585	–	–	3.89%	8
2021 Q4	$84.6M	Hold	5,058,585	–	–	4.32%	10
2021 Q3	$82.2M	Buy	5,058,585 +3,100	+0.1%	+$33.7K	4.04%	10
2021 Q2	$31.9M	Buy	5,055,485 +2,271,402	+82%	+$14.7M	1.28%	16
2021 Q1	$17.2M	Buy	2,784,083 +2,626,407	+1,666%	+$15.9M	0.78%	17
2020 Q4	$1.09M	Buy	+157,676	New	+$1.01M	0.05%	24

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Yiheng Capital Management's ISEE Position: Q2 2023 in Review

Yiheng Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 2,143,497 shares — an estimated $52.2M sold.

Yiheng Capital Management first reported a position in ISEE in Q4 2020 and held it in 10 quarters. The position peaked at $85.1M in Q1 2022. 255 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

Yiheng Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Yiheng Capital Management sold 2,143,497 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $52.2M.
Yiheng Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2020 and held it in 10 quarters.
Yiheng Capital Management's IVERIC bio, Inc. Common Stock position peaked at $85.1M in Q1 2022.
255 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Yiheng Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.